ABCL - 086
Trial in Progress (IGNITE): A Phase 3, Multiregional, Open-Label, Randomized Study of Tirabrutinib vs Rituximab and Temozolomide (RTX-TMZ) in Relapsed/Refractory (R/R) Primary Central Nervous System Lymphoma (PCNSL)
Lakshmi Nayak
Poster Presenter: Lakshmi Nayak
